亚斯科特-BPLA是一家

Same author

PSA Screening and Prostate Cancer Mortality.

JAMA·2024

Same author

Inflammation, infection, and cardiovascular risk.

Lancet (London, England)·2024

Same author

Bempedoic Acid for Primary Prevention of Cardiovascular Events.

JAMA·2023

Same author

Comment regarding: "COVID-19 vaccination may enhance hippocampal neurogenesis in adults".

Brain, behavior, and immunity·2022

Same author

Identifying those at risk for COVID-19 related suicide. Response to "Hyper/neuroinflammation in COVID-19 and suicide etiopathogenesis: Hypothesis for a nefarious collision?"

Neuroscience and biobehavioral reviews·2022

Same author

The Increasing Incidence of Early-Onset Colorectal Cancer.

The New England journal of medicine·2022

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

相关实验视频

亚斯科特-BPLA是一家

相关概念视频

PSA Screening and Prostate Cancer Mortality.

Inflammation, infection, and cardiovascular risk.

Bempedoic Acid for Primary Prevention of Cardiovascular Events.

Comment regarding: "COVID-19 vaccination may enhance hippocampal neurogenesis in adults".

Identifying those at risk for COVID-19 related suicide. Response to "Hyper/neuroinflammation in COVID-19 and suicide etiopathogenesis: Hypothesis for a nefarious collision?"

The Increasing Incidence of Early-Onset Colorectal Cancer.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

相关实验视频

亚斯科特-BPLA是一家

相关概念视频

相关文章

PSA Screening and Prostate Cancer Mortality.

Inflammation, infection, and cardiovascular risk.

Bempedoic Acid for Primary Prevention of Cardiovascular Events.

Comment regarding: "COVID-19 vaccination may enhance hippocampal neurogenesis in adults".

Identifying those at risk for COVID-19 related suicide. Response to "Hyper/neuroinflammation in COVID-19 and suicide etiopathogenesis: Hypothesis for a nefarious collision?"

The Increasing Incidence of Early-Onset Colorectal Cancer.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.